News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Cytovance Biologics and Alcami Collaborate to Offer Comprehensive Solutions for Biologics Development
Monday, December 11, 2023Cytovance Biologics has recently unveiled a strategic partnership with Alcami Corporation another Contract Development and Manufacturing Organization
NextPoint Therapeutics' NPX887 Clears FDA IND for Reactivating Immune Cells in HHLA2+ Solid Tumors
Friday, December 08, 2023NextPoint Therapeutics a biotechnology company in the clinical stage has disclosed the acceptance of its investigational new drug application by the US Food Drug Administration
FDA Clears Vittoria Biotherapeutics' IND Application for VIPER-101 to Address T-Cell Lymphoma
Friday, December 08, 2023Vittoria Biotherapeutics has achieved a significant milestone with the clearance of its Investigational New Drug application by the US Food and Drug Administration This clearance paves the way for the initiation
Velocity Clinical Research Extends Its Operations Into Poland
Thursday, December 07, 2023Velocity Clinical Research a renowned organization specializing in clinical research across diverse medical fields has announced its expansion into Poland through the acquisition of its inaugural center ClinMedica Research
Rumi Scientific and X-Chem Collaborate to Advance Lead Candidate in Huntington’s Disease Research
Wednesday, December 06, 2023Rumi Scientific a company focused on developing therapies for rare and neurodegenerative diseases using its high throughput organoid phenotypic screening platform has announced a collaboration with XChem
Philogen S.p.A. Receives GMP Certification for New Production Facility in Rosia, Italy
Wednesday, December 06, 2023Philogen SpA is thrilled to announce that its new GMP facility in Rosia Siena has received GMP certification The Agenzia Italiana del Farmaco
CN Bio's PhysioMimix Organ-on-a-Chip Data Backs Inipharm’s INI-822 in Clinical Trials for Treating Metabolic Liver Disease
Tuesday, December 05, 2023CN Bio a prominent OrganonaChip company specializing in the development of microphysiological systems for single and multiple organs has announced the significance of its PhysioMimix
Acino Successfully Finalizes the Acquisition of M8 Pharmaceuticals, Significantly Expanding Its Presence and Capabilities in Latin America
Tuesday, December 05, 2023Acino a Swiss pharmaceutical company based in Zurich has recently finalized the acquisition of M Pharmaceuticals a rapidly growing specialty biopharmaceutical firm headquartered in Mexico City M focuses on licensing
Cancer Research UK and Guardant Health Collaborate to Propel Progress in Cancer Research and Clinical Development Activities
Monday, December 04, 2023Cancer Research UK a major global funder of cancer research and Guardant Health a leading precision oncology company have recently announced a collaboration aimed at enhancing the development and precision of cancer
Ambio Secures FDA Approval for Generic Teriparatide Injection, Collaborates With Apotex on Forteo® Substitute
Saturday, December 02, 2023Ambio Inc a forwardthinking biotech company specializing in the development of novel peptide drugs biosimilars bioequivalents and other intricate generic drugs announced today that the US Food and Drug Administration
